Newstral
Article
Seattle Times on 2021-08-23 17:47
Senators question FDA on work with opioid maker consultant
Related news
- Senators question FDA on work with opioid maker consultant thedailyrecord.com
- Senators Slam FDA Nominee Gottlieb As Being Too 'Cozy' With Big Pharma To Combat Opioid EpidemicForbes
- Senators: NH underfunded in opioid crisisSeacoastonline.com
- Senators call on FDA to ban sale of menthol cigarettesWXII
- OxyContin's maker is accused of fueling the opioid epidemic. Its new overdose antidote was just fast-tracked by the FDACNN
- ADemocratic senators seek assurances from Trump pick for FDAapnewsarchive.com
- FDA announces overhaul of approach to opioid painkillersThe Day
- Senators slam bonuses for execs of OxyContin maker Purdue PharmaNew York Post
- AGs Question FDA Plan for Mail-Back Opioid Programjdsupra.com
- Lawmakers scrutinize McKinsey’s opioid, FDA consulting workthedailyrecord.com
- Sen. Markey blocking FDA nominee on opioid approval concernsMerced Sun-Star
- US senators call on FDA to ban sale of menthol cigaretteswtnh.com
- HManchin Urges FDA Changes to Properly Fight Opioid Epidemichuntingtonnews.net
- Democrat holds up nomination for FDA chief over opioid reviewsstaradvertiser.com
- Biden in standoff with Democratic senators over who should lead FDACNN
- U.S. senators call on FDA to ban sale of menthol cigarettes - Sat, 26 Aug 2017 PSTThe Spokesman-Review